La cadena de opciones muestra datos clave de las opciones de acciones de Equinox Gold a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Equinox Gold..

Equinox Gold (AMEX:EQX) Bolsa, Cadena de Opciones

Equinox Gold

Equinox Gold Corp is a mining company engaged in the operation, acquisition, exploration, and development of mineral properties, with a focus on gold. Equinox Gold has around seven operating gold mines and a clear plan to increase production by advancing the pipeline of growth projects. Geographically, the company operates in the United States, Mexico, and Brazil. The majority of its revenue is generated from Canada.

Gold,Bar,On,Candlestick,Chart,Background.,Conceptual,Image,Of,Gold

Equities

News

Commodities

Markets

Movers

PPTA

El oro se dispara y los inversores reaccionan. John Paulson aumenta su posición en mineras clave, mientras el mercado sigue su escalada.

Acciones de minería de oro en auge: los valores que dispararon la fortuna de John Paulson

General

Redwire Announces Edge Autonomy Stalker Uncrewed Aerial System Added To Department of Defense's Blue List of Approved Drones

CollPlant Biotechnologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLGN#NASDAQ">CLGN</a>), a regenerative and aesthetics medicine company developing disruptive technologies and products based on its non-animal-derived recombinant human collagen (rhCollagen), today announced the appointment of Bowman Bagley as Vice President, Commercial North America. In this newly created role, Mr. Bagley will lead the company's commercial strategy and execution in North America, including sales and marketing, logistics, and expansion of market presence for CollPlant's rhCollagen-based products and platforms.
 &nbsp;

CLGN

CollPlant Taps Bowman Bagley to Lead North American Push for Skin and Tissue Tech

Biotech

TECH

Bio-Techne Says Its Simple Western Technology Played A Role In Supporting FDA Approval Of Abeona's ZEVASKYN

WKHS

Workhorse Is Currently In Discussions With A Privately Held US-Based Manufacturer Of Electric Commercial Vehicles About A Potential Transaction In Which The Manufacturer Would Be Merged Into A Newly Created Subsidiary Of The Company In Exchange For Newly Issued Shares Of The Company's Common Stock

Aurora Cannabis' Distribution Centre In Brampton, Ontario, Granted EU-GMP Certification, Increasing Company's International Export Capabilities

Goldman Sachs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) has initiated coverage on Nebius Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NBIS#NASDAQ">NBIS</a>) with a Buy rating and a price target of $68. This suggests a potential upside of about 53.49% from the stock&#8217;s closing price on Friday.
What Happened: Goldman Sachs identified Nebius as a major player in the AI Neocloud market, offering AI GPU infrastructure rental services that support the fast-growing Generative AI sector, <a href="https://www.investing.com/news/analyst-ratings/goldman-sachs-initiates-nebius-group-stock-with-buy-rating-68-target-93CH-4132970">reported</a> Investing.com.
The investment bank emphasized Nebius's key strengths, including its comprehensive software suite, cost efficiency, and proven ability to operate at scale—advantages that set it apart from other GPU rental providers. While the stock has seen recent gains, Goldman Sachs believes Nebius's AI infrastructure business is still undervalued relative to its industry peers.
See Also: <a href="https://benzinga.com/news/topics/25/07/46384959/faa-boeing-say-fuel-switch-locks-on-787-dreamliner-are-safe-amid-air-india-crash-probe" target="_blank" rel="noopener">FAA, Boeing Say Fuel Switch Locks On 787 Dreamliner Are Safe Amid Air India Crash Probe</a>
Goldman Sachs anticipates a "supportive catalyst path" over the next 12 months, which it believes will drive further stock outperformance and reinforce the firm's positive risk-reward outlook.
Why It Matters: Nebius Group has been making significant strides in the AI industry. The company&#8217;s stock has seen a staggering <a href="https://www.benzinga.com/content/46375205/nebius-group-up-385-analysts-say-its-still-a-bargain">385% year-over-year revenue growth</a> in its latest quarter. In the first quarter of 2025, the company posted revenues of $55.3 million, marking a 385% increase compared to the same period last year.
Nebius Group is among the earliest adopters of Nvidia Corp.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) full-stack approach to <a href="https://www.benzinga.com/content/45993702/why-nebius-group-is-one-of-the-top-ai-stocks-to-watch">AI infrastructure</a> and is a Reference Platform NVIDIA Cloud Partner.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://benzinga.com/news/politics/25/07/46383817/jeffrey-epstein-in-tapes-released-by-michael-wolff-i-was-donalds-closest-friend" target="_blank" rel="noopener">Jeffrey Epstein in Tapes Released by Michael Wolff: &#8216;I Was Donald&#8217;s Closest Friend&#8217;</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo: Shutterstock

Tech

NBIS

NVDA

Goldman Sachs Sees 53% Upside In Nebius Group, Calls AI Infrastructure 'Undervalued'

VOYA

Blue Owl Capital And Voya Financial Partner To Develop Private Markets Investment Products For Defined Contribution Retirement Plans

The UK government has announced it will invest over £63M ($84M) to boost EV charging infrastructure all over the country to encourage EV adoption.
What Happened: The UK's Secretary of State for Transport, Heidi Alexander, shared that she wanted to make switching to EVs more affordable in the UK and announced additional funding to build charging infrastructure, The Guardian reported <a href="https://www.theguardian.com/politics/2025/jul/13/uk-funding-ev-charging-infrastructure-electric-vehicles">on</a> Sunday.
The report also suggested that the government is working on a £700M ($944M) subsidy package that would help make electric cars more affordable in the UK, though no official announcement has been made yet.
"We do need to make it easier and cheaper for people to buy an electric vehicle. So today we're announcing really big investment, £63M in charging infrastructure across the country,"
However, the government subsidies may not apply to EVs from manufacturers of premium or luxury vehicles like Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) or Jaguar Land Rover, the report suggests.
Why It Matters: The news comes in as Tesla sales have experienced an uptick in the UK, with the company recording <a href="https://www.benzinga.com/markets/tech/25/07/46257617/elon-musk-led-tesla-sales-surge-12-in-the-uk-during-june-q2-deliveries-beat-analyst-estimates">a 12% YoY surge</a>, selling 7,189 units during June.
However, Tesla sales have declined significantly across multiple markets amid company CEO Elon Musk's <a href="https://www.benzinga.com/news/politics/25/07/46384692/elon-musk-says-trump-wants-everyone-to-stop-talking-about-epstein-reiterates-demand-that-president-just-release-the-files">ongoing feud</a> with President Donald Trump over the latter's Big Beautiful Bill that repeals the <a href="https://www.benzinga.com/markets/tech/25/07/46289556/trumps-tax-bill-axes-the-7500-ev-credit-heres-how-you-can-still-claim-it">$7,500 EV credit</a>, while also potentially affecting the <a href="https://www.benzinga.com/markets/tech/25/07/46258669/tesla-made-2-76-billion-from-zev-credits-in-2024-in-us-but-trumps-tax-bill-just-killed-this-revenue-stream">sales of ZEV credits</a>.
Elsewhere, Musk has shared a teaser on social media platform X, promising an "epic" demo at the <a href="https://www.benzinga.com/markets/tech/25/07/46386130/elon-musk-teases-most-epic-demo-ever-by-2025-end-as-tesla-struggles-amid-declining-sales-trump-ending-ev-mandate">end of the year</a> by Tesla, igniting speculation about the Optimus line of robots as well as the Cybercab.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="1024" height="199" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/14063252/Telsaa2-1-1024x199.jpg" alt="" class="wp-image-983702" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/14063252/Telsaa2-1-1024x199.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/14063252/Telsaa2-1-300x58.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/14063252/Telsaa2-1-768x149.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/14063252/Telsaa2-1-1536x299.jpg 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/07/14063252/Telsaa2-1.jpg 1574w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Tesla offers satisfactory Momentum and Quality while scoring well on the Growth metric, but offering poor Value. For more such insights, sign up for <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Benzinga Edge Stock Rankings</a> today!
Check out more of Benzinga&#8217;s Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46386564/will-your-tesla-car-support-grok-only-these-vehicles-will-be-able-to-run-elon-musk-led-xais-latest-ai-model">Will Your Tesla Car Support Grok? Only These Vehicles Will Be Able To Run Elon Musk-Led xAI&#8217;s Latest AI Model</a></li>
</ul>
Photo courtesy: VTT Studio / Shutterstock.com

TSLA

UK Commits $84 Million To Charging Infrastructure, Plans $944 Million Subsidy Package—Tesla May Be Left Out

The GEO Group, Inc. (NYSE:<a href="https://www.benzinga.com/stock/GEO#NYSE">GEO</a>) ("GEO" or the "Company") announced today the closing of an amendment to the Company's Credit Agreement dated as of April 18, 2024 (the "Amendment"). The Amendment increases GEO's Revolving Credit Facility (the "Revolver") commitments from $310 million to $450 million and extends the Revolver's maturity to July 14, 2030. The Amendment further provides that interest will accrue on outstanding revolving credit loans at a rate determined with reference to the Company's total leverage ratio. As of today, revolving credit loans accruing interest at a SOFR based rate would accrue interest at the term SOFR reference rate for the applicable interest period plus 2.75% per annum, which is lower by 0.50% from the applicate rate prior to the Amendment. The Amendment also increases GEO's capacity to make restricted payments over the next five years.
Prior to the closing of the Amendment, GEO repaid $132 million of the Term Loan B outstanding under the Credit Agreement. Further, as previously disclosed, GEO expects to use net proceeds from the sale of the GEO-owned Lawton Correctional Facility in Oklahoma, which is expected to close on July 25, 2025, to pay off additional senior secured debt, including the remaining balance of the Term Loan B outstanding under the Credit Agreement. These two transactions are expected to reduce GEO's total net debt to approximately $1.47 billion and position GEO to consider potential future capital returns.

GEO Group Expands Credit Line to $450M, Aims to Cut Debt With Oklahoma Prison Sale

HC Wainwright &amp; Co. analyst Raghuram Selvaraju initiates coverage on Serina Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SER#AMEX">SER</a>) with a Buy rating and announces Price Target of $15.

Price Target

Initiation

Analyst Ratings

HC Wainwright & Co. Initiates Coverage On Serina Therapeutics with Buy Rating, Announces Price Target of $15

A federal judge on Friday vacated a Biden-era rule that would have stripped medical debt from consumer credit reports, siding with credit-industry and Trump-administration arguments that regulators overreached.
What Happened: According to a Reuters report, U.S. District Judge Sean Jordan said the Consumer Financial Protection Bureau rewrote the Fair Credit Reporting Act when it finalized the policy in January, a move he ruled exceeded the agency's authority.
His decision blocks a measure the CFPB estimated would erase about $49 billion in liabilities from the records of 15 million Americans and bar lenders from using medical data in loan decisions. The judge, a 2019 Donald Trump appointee, noted that Congress lets credit bureaus report coded medical debts and that federal law pre-empts stricter state limits.
Experian, Equifax and TransUnion argued the rule would give lenders an incomplete picture of a borrower's ability to repay, even after they voluntarily stopped listing medical collections under $500 in 2022. "This is the right outcome for protecting the integrity of the system," Consumer Data Industry Association chief executive Dan Smith <a href="https://www.cdiaonline.org/news/2025/07/11/court-vacates-cfpb-rule-on-medical-debt/">said</a>.
See also: <a href="https://www.benzinga.com/personal-finance/financial-advisors/25/07/46386533/dave-ramsey-warns-bankruptcy-is-huge-red-flag-that-can-delay-homeownership-by-years">Dave Ramsey Warns Bankruptcy Is &#8216;Huge Red Flag&#8217; That Can Delay Homeownership By Years</a>
Why It Matters: The Biden administration adopted the ban after research showed medical bills, which include shocks from accidents or hospital stays, distort credit scores yet reveal little about long-term solvency. Roughly one in 12 adults carries <a href="https://www.kff.org/key-facts-about-hospitals/?entry=out-of-pocket-spending-and-medical-debt-medical-debt">at least</a> $250 in unpaid medical debt. A CFPB statement in January called the measure a common-sense fix for families who would see scores rise by as much as 20 points.
Consumer advocates condemned Friday's ruling and urged the White House to appeal, but the Justice Department has not defended the rule since the CFPB reversed course under President Trump. The policy's <a href="https://www.benzinga.com/personal-finance/financial-advisors/25/05/45185435/medical-debt-rule-on-the-brink-who-is-impacted">fate grew uncertain</a> after that reversal, warning millions could still face higher borrowing costs.
The now-vacated rule anchored a broader White House strategy that also <a href="https://www.ncdhhs.gov/news/press-releases/2025/02/05/hospital-payment-program-and-medical-debt-relief-initiative-approved-another-year">steered</a> Medicaid funds to North Carolina hospitals that forgave patient balances.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/politics/25/07/46387398/trump-accepts-king-charles-invite-for-rare-second-state-visit-to-uk-amid-political-backlash">Trump Accepts King Charles&#8217; Invite For Rare Second State Visit To UK—Amid Political Backlash</a></li>
</ul>
Photo Courtesy: Salma Bashir on Shutterstock

Health Care

Texas Judge Blocks Biden-Era Rule Meant To Erase $49 Billion In Medical Debt From Credit Reports

HC Wainwright &amp; Co. analyst Raghuram Selvaraju initiates coverage on Innoviva (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INVA#NASDAQ">INVA</a>) with a Buy rating and announces Price Target of $40.

INVA

HC Wainwright & Co. Initiates Coverage On Innoviva with Buy Rating, Announces Price Target of $40

Insider Trades

Robert Leshner Reported A 56.9% Stake In LQR House In 13D Filing

<ul>
<li>Appoints Current Kenvue Director and Proven CPG and Technology Company Leader, Kirk Perry, as Interim CEO, Effective Immediately</li>
<li>Announces Ongoing Review of Strategic Alternatives</li>
<li>Reports Select Preliminary Second Quarter 2025 Financial Results</li>
</ul>
Kenvue Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KVUE#NYSE">KVUE</a>) today announced that its Board of Directors is implementing a set of actions to enable the Company to unlock shareholder value and reach its full potential. The Board has made a Chief Executive Officer transition and is advancing an ongoing comprehensive review of strategic alternatives.
Advancing Strategic Review
The Board had previously initiated a comprehensive review of strategic alternatives and has established a Strategic Review Committee to oversee the ongoing process. The strategic review will consider a broad range of potential alternatives, including optimizing the Company's brand portfolio, while improving execution and enhancing operating performance to accelerate profitable growth and unlock the inherent value in Kenvue.
The Board and the Strategic Review Committee are being advised by Centerview Partners and McKinsey &amp; Company. The Company plans to update shareholders as the strategic review progresses.

KVUE

Kenvue Board Forms Committee For Strategic Review With Centerview and McKinsey Advisors To Accelerate Growth And Value

Needham analyst Bernie McTernan maintains Uber Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) with a Buy and raises the price target from $100 to $109.

UBER

Needham Maintains Buy on Uber Technologies, Raises Price Target to $109

Fastenal (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FAST#NASDAQ">FAST</a>) reported quarterly earnings of $0.29 per share which beat the analyst consensus estimate of $0.28 by 3.57 percent. This is a 11.54 percent increase over earnings of $0.26 per share from the same period last year. The company reported quarterly sales of $2.08 billion which beat the analyst consensus estimate of $2.07 billion by 0.28 percent. This is a 8.56 percent increase over sales of $1.92 billion the same period last year.

Earnings

Earnings Beats

FAST

Fastenal Q2 EPS $0.29 Beats $0.28 Estimate, Sales $2.08B Beat $2.07B Estimate

Hesai Group ("Hesai" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSAI#NASDAQ">HSAI</a>), the global leader in three-dimensional light detection and ranging (lidar) solutions, today announces that it has filed a Notice of Appeal to the U.S. Court of Appeals on July 13, 2025, to challenge the decision of the U.S. District Court for the District of Columbia ("District Court"), which upheld the U.S. Department of Defense's (DoD) designation of the Company under Section 1260H of the National Defense Authorization Act for Fiscal Year 2021.
"We are deeply disappointed by the District Court's ruling and respectfully disagree with its decision. We believe the DoD's designation lacks both factual and legal bases," said Yifan "David" Li, the CEO of Hesai. "We are appealing to the U.S. Court of Appeals, and we will vigorously pursue all legal avenues to protect our reputation and seek fair treatment."
Critically, the District Court acknowledged that the DoD found no evidence that Hesai's products have been used for military purposes, nor any evidence of a direct or indirect connection between Hesai and the Chinese military — fundamental facts Hesai has maintained all along.
Instead, the District Court based its ruling solely on two factors: the geographic location of Hesai's R&amp;D centers within certain industrial districts, and the theoretical potential that technologies such as lidar could have military applications. These speculative rationales—which could apply equally to countless other companies operating in China, including American and international companies—fall far short of demonstrating that Hesai has actually contributed to the military in any way, as the statute requires.
Hesai has never developed, supplied, or certified products for military use, as its products are solely for civilian and commercial uses. Hesai will continue to defend its integrity and pursue appropriate legal remedies. At the same time, Hesai remains focused on delivering cutting-edge lidar solutions to its global customers and maintaining its unwavering commitment to transparency and good corporate governance as a Nasdaq-listed company.

Legal

HSAI

Lidar Maker Hesai Fights Pentagon Blacklist, Appeals US Court Ruling Over China Ties

HC Wainwright &amp; Co. analyst Raghuram Selvaraju reiterates Abeona Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABEO#NASDAQ">ABEO</a>) with a Buy and maintains $20 price target.

Reiteration

ABEO

HC Wainwright & Co. Reiterates Buy on Abeona Therapeutics, Maintains $20 Price Target

Castellum, Inc. (NYSE-American: CTM) (the "Company" and "Castellum"), a cybersecurity, electronic warfare, and software services and solutions company focused on the federal government, releases this letter to shareholders from <a href="https://www.globenewswire.com/Tracker?data=3Umz9Wpg3-fccBTbn9THik7dLcOSVg9GMThkCmzsLS_muZDDRiZOkk19lAwjWxES8C9Q7lJZawc9fwBYsbJAN3Z01Mkbk41sJX6LbF_ZJAoJUvbh2kt6ndEwm4foQW66Xw3BwIXKZLPYRItgqAlyuTXpuphZT2d-ucsILggdZ70=">Chief Executive Officer ("CEO"), Glen Ives.</a>
Dear Fellow Shareholders:
With this month marking the one-year anniversary of my time as your CEO, I thought it an opportune time to thank you sincerely for your support and confidence in<a href="https://www.globenewswire.com/Tracker?data=2a-c6V_SP0k-aNXr_WWhzeaydRYjCsL9JpsSaqiVUm96O2ERlaeTdQd5BELP0rua7rU7gOpLhTPsdYDsoU-U7ZYc2ZKCe790u6IFh30RRc8="> Castellum, Inc</a>., re-emphasize how incredibly honored I continue to be to have this opportunity to lead <a href="https://www.globenewswire.com/Tracker?data=itxch3VDyJLd9KwH02kos34hghcUriOfAe1-JVQ8vNtPbHAvJWJyVYRRpebvJsiP6WkZT7ww7qW6Ap04qBLWo1pgfI4fUnNZHlHS-CEgo6M=">our CTM team,</a> provide a very brief update on our significant progress over this past year, and explain why I continue to be encouraged, confident, and genuinely excited for all of us at CTM as we look ahead.
Since I assumed my role as your CEO on July 1st of last year, CTM has quickly and strategically transitioned from our four-year Phase 1 "start-up" period, during which we were focused on acquiring and integrating seven companies and uplisting to the NYSE American LLC ("NYSE American"). Last July, we made a strategic pivot to Phase 2, focusing on strengthening our foundational platform through <a href="https://www.globenewswire.com/Tracker?data=JjodBAMH549HWzAwS7tXjOiKpx0zLDQEzWt3HYx6vssCkgtEySo2Bq86ChjYHXCnvot4BvBSL0zmaHRks8AEV-0PMAzr9Jixioli6h2x2-FYnO7mSWbLapsac8Wz2ohoD18KCyOxH276bEsInn4_0zyjlxFh_XVl4PrVAkRLn3sC-jO2KG_ge-TPZKLXcQJeubyuzFscHO677NFRtu1vqnTtMkZaV7iAl7ui5O03NoWsytbIy8-gRedpqTTHcJToHoHFPyWt-1fFZV7zyJEd-Q==">organic growth.</a>&nbsp;As I have affirmed constantly, time and again since last summer, our Phase 2 strategy is based upon a total, 100%, uncompromising, "all hands" commitment to organic growth.
Over the past year, our CTM Team has been improving and energizing every aspect of our Company to compete in the "full and open" arena, as defined by the government, as a "large" business. We are completely integrated across CTM in every business function and have been laser focused on strengthening business development ("BD") and organic growth through a broadening, deepening, and quality improvement of our opportunity pipeline and significantly enhancing our prospective capabilities in the key BD areas of opportunity development, capture management, and proposal development.
Here's a brief recap of what we have accomplished <a href="https://www.globenewswire.com/Tracker?data=4BW0BAupTf-yMj0RzAGbdL9_slwNItZcIXpOcwI8JfqxuwKLu-5XU8t8ewpVx7WgVKHICHCk91682dIyVFdM1Q7C6XcSnqdA5svhtA_rQ5NYHazIhlDJzF3Tus7Gn4Lv">since July 1, 2024</a>:
<ul>
<li>Leadership team restructured and strengthened with greater industry and technology experience:</li>
<li>Raised over $16 million through public offerings and warrant exercises;</li>
<li>Reduced our <a href="https://investors.castellumus.com/news/news-details/2025/Castellum-Inc--Retires-Promissory-Note-Early/default.aspx">long-term debt to less than $5 million today</a>;</li>
<li>Strong and healthy balance sheet – Improved cash/equity to debt ratio;</li>
<li>Won largest prime contract in CTM history with <a href="https://investors.castellumus.com/news/news-details/2025/Castellum-Inc.-Announces-the-Award-of-a-103.3-million-Contract-to-its-GTMR-Subsidiary/default.aspx">$103.3&nbsp;million, a 5.5-year&nbsp;contract for Special Missions</a>&nbsp;support of the Naval Air Systems Command Program Office PMA 290 Special Missions;</li>
<li>Established <a href="https://investors.castellumus.com/news/news-details/2025/Castellum-Inc.s-SBA-Protgs-Successfully-Onboard-to-SeaPort-NxG-Contract/default.aspx">two mentor-protégé relationships</a>&nbsp;and related joint ventures with woman-owned and native Hawaiian organizations;</li>
<li>Established a <a href="https://investors.castellumus.com/news/news-details/2025/Castellum-Inc--Announces-Creation-of-New-Subsidiary-to-Focus-on-Advanced-Technology-Products/default.aspx">new subsidiary</a> to focus on advanced technology products;</li>
<li>Consistent "best in industry" contractor performance assessment reports ("CPARS"), which is our "report card" from our government customers; and</li>
<li>Significant improvement and increases in the volume and quality of our proposals ... for baseball fans, we want to get more at-bats, take more swings at the right pitches, get on base more with a good balance of singles, doubles, triples, and home runs.</li>
</ul>
Today, we are an intensely competitive, leading-edge technology services and solutions team committed to national security and our warfighters. We provide relevant, timely, and world-class mission services and solutions to our defense and federal civilian customers through our government-awarded contracts. <a href="https://www.globenewswire.com/Tracker?data=RZD3Ht1ZP4si6EUCCdqTSs2I0Ge8Qr6nlNI88VUL28feThPODPMlAWdmijjZPAUdWiZi5dgBwPNBMylPae0jmrg8tBOUVvRMyVvJnHfVCiow_0prdbJS2uQBQhvxlW40p8cOI0c5lcRbGwrQvoP9PPg8cqVeol2TO4b-bmu3Yq4=">We bring unparalleled capabilities</a> in software and systems engineering and integration, software development, and model-based systems engineering across every technology domain and mission area vital to our government mission customers. Going forward, our new advanced technology products subsidiary will complement our historic strong suit of tech-enabled services with the tech itself.
Relevant, powerful, high-demand, high-value technology domains and mission capabilities:
<ul>
<li>Software development, software and systems engineering, systems integration, model-based systems engineering;</li>
<li>Electronic and information warfare;</li>
<li>Cybersecurity, AI/ML, data analytics, digital modernization, <a href="https://c5isrcenter.devcom.army.mil/">C5ISR</a>;</li>
<li>Data and intelligence analysis; and</li>
<li>Strategic mission, policy planning, and development.</li>
</ul>
At the very core, we have built and are building a premier, cohesive team - I couldn't be prouder of the whole team we have built, top to bottom, left to right. We have brought together seven different companies, professionals from outside those organizations, and built an integrated and focused team that has been responsible for the many positive things that have happened, are happening, and will continue to happen.
<ul>
<li>With the equity raises, we will be able to lean into investments we are already making - business development and IT for organic growth, and it will allow us to pursue growth by acquisitions;</li>
<li>Contract wins will build success – credibility, service, and revenue;</li>
<li>Strong CPARS speaking to the high quality of our work;</li>
<li>Increase in proposals – improves our opportunities for winning; and</li>
<li>With our mentor-protégé joint ventures, we grow our business and help establish two worthy companies.</li>
</ul>
We are now where we wanted to be when we first uplisted to the NYSE American in October 2022. We have now raised the capital we intended to support our organic and inorganic growth strategies. Since the time of uplisting, we have honed our skills and integrated our teams to be a better, stronger company. We are committed to winning and growing contracts, as well as making strategic acquisitions, to achieve our goal of becoming a large, premier defense company.

Castellum CEO Marks 1 Year With Big Contract Wins, Lower Debt, and Plans to Grow Defense Tech Business

Press Releases

Equinox Gold Provides Update on the Los Filos Mine

Equinox Gold Shareholders Receive Positive Voting Recommendations for Business Combination with Calibre Mining

Equinox Gold and Calibre Mining Amend Arrangement Agreement in Respect of Proposed Business Combination, Announce Adjournment of Respective Shareholder Meetings, New Meeting Dates Set for May 1, 2025

Equinox Gold to Announce First Quarter Financial and Operating Results on May 7, 2025

Calibre Securityholders Approve Business Combination with Equinox Gold

Equinox Gold Announces Results from Adjourned Annual & Special Meeting of Shareholders: Shareholders Approve Business Combination with Calibre Mining

Equinox Gold Reports First Quarter 2025 Financial and Operating Results

Equinox Gold Provides Updated 2025 Gold Production and Cost Guidance, 2025 Full-year Pro Forma Guidance, Including Calibre Mining Assets, of 785,000 - 915,000 Ounces of Gold, Greenstone Mine Expecting Strong H2 2025

Comments

Equinox Gold

Equinox Gold (EQX) Opciones

Equinox Gold (AMEX:EQX) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL